0001104659-22-071014.txt : 20220614
0001104659-22-071014.hdr.sgml : 20220614
20220614161608
ACCESSION NUMBER: 0001104659-22-071014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220613
FILED AS OF DATE: 20220614
DATE AS OF CHANGE: 20220614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jacobs John C
CENTRAL INDEX KEY: 0001820836
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39450
FILM NUMBER: 221015066
MAIL ADDRESS:
STREET 1: 630 W. GERMANTOWN PIKE
STREET 2: SUITE 215
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc.
CENTRAL INDEX KEY: 0001802665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822279923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 630 W GERMANTOWN PIKE
STREET 2: SUITE 215
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
BUSINESS PHONE: (484) 539-9800
MAIL ADDRESS:
STREET 1: 630 W GERMANTOWN PIKE
STREET 2: SUITE 215
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
4
1
tm2218405-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-06-13
0
0001802665
Harmony Biosciences Holdings, Inc.
HRMY
0001820836
Jacobs John C
630 W. GERMANTOWN PIKE, SUITE 215
PLYMOUTH MEETING
PA
19462
1
1
0
0
President, CEO
Common Stock
2022-06-13
4
M
0
25000
8.22
A
25000
D
Common Stock
2022-06-13
4
S
0
9803
43.6331
D
15197
D
Common Stock
2022-06-13
4
S
0
15197
44.5269
D
0
D
Stock Option
8.22
2022-06-13
4
M
0
25000
0
D
2027-10-02
Common Stock
25000
169751
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.02 to $44.01. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.02 to $44.89. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The stock option vests in five equal annual installments beginning on October 1, 2018.
/s/ Christian Ulrich, Attorney-in-fact
2022-06-14